Worldwide Non-Alcoholic Fatty Liver Disease (NAFLD) Market: Industry insight, Benefits and outlook till 2023


Posted June 1, 2019 by jadhavni3

The exclusive research report on the Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market 2019 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

 
Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market Overview:

The Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market research report is the investigation arranged by investigators, which contain a point by point examination of drivers, limitations, and openings alongside their effect on the Non-Alcoholic Fatty Liver Disease (NAFLD) Market development (2019 - 2023).

The Non-Alcoholic Fatty Liver Disease (NAFLD) is the presence of hepatic steatosis in the absence of competing liver disease. It is a spectrum of liver disorders associated with steatosis, with no evidence of significant alcohol consumption.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/115942 .

According to the market research report, Non-Alcoholic Fatty Liver Disease (NAFLD) is one of the most common diseases in the US. The prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) is increasing due to rise in prevalence of diabetes and obesity. As per the National Health and Nutrition Examination survey, about 20-30% of the general population in the western world suffer from Non-Alcoholic Fatty Liver Disease (NAFLD). The common symptoms include fatigue, weakness, weight loss and others. The Non-Alcoholic Fatty Liver Disease (NAFLD) diagnosis requires the combination of different tests such as blood test, ultrasound, CT scan, MRI scan, and liver biopsy. The two types of Non-Alcoholic Fatty Liver Disease (NAFLD) include simple fatty liver and Nonalcoholic Steatohepatitis (NASH).

The Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market is segmented on the basis of Type, Distribution Channels and Region. On the basis of Type, the market is sub-segmented into Antioxidants, Thiazolidinedione, Biguanides, Lipid lowering Agents, FXR Receptor Agonist and others. On the basis of Distribution Channels, the market is divided into Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Pharmacy and others.

In terms of the regional analysis, North America is estimated to lead the Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market due to increase in prevalence of diabetes and cardiovascular diseases in US. Large number of manufacturers exists in the market, with large number of customer base. APAC market is also projected to experience high growth in the near future owing to factors such as, increase in healthcare expenditure, rising standard of living, lifestyle changes- attributed to better healthcare and awareness of the cost-effective treatment process with government grants and funding for acceleration in research and development activities.

Industry News:

Daewoong Pharmaceutical (March 14, 2019) – Daewoong Pharmaceutical leads innovation of local business by focusing on technology transfer with Trapaco, the largest pharmaceuticals company in Vietnam – Daewoong Pharmaceutical (CEO Sengho Jeon) announced on the 14th that they started the kick-off meeting for technology transfer and local production with Trapaco, one of ‘Big 2’ pharmaceutical companies in Vietnam whose shares were acquired in 2017. With this technology transfer and production, Trapaco will be able to improve their technology in the ethical drugs (ETC) and Daewoong Pharmaceutical will be able to join the local bidding group in Vietnam.

Daewoong Pharmaceutical has selected eight products to be produced and supplied at Trapaco’s new factory, including Urusa, with plans to transfer the production technology for ingredient sourcing, equipment purchasing, analyzing, and test production during 2019 and start selling the products in 2021. Trapaco will create the sales and marketing organizations for Daewoong Pharmaceutical’s products to take charge of production, sale, and distribution in Vietnam.

Top Leading Key Manufacturers are: Conatus Pharmaceuticals, Daewoong Pharmaceutical, Galmed International, Kyorin Pharmaceutical, Metabolic Solutions Development, Novartis AG, Phenex Pharmaceuticals, Raptor Pharmaceuticals, TCM Biotech International, Tobira Therapeutics, Verva Pharmaceuticals, Zafgen and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Purchase this report online with 125 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market Report 2019” @ https://www.businessindustryreports.com/buy-now/115942/single .

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Non-Alcoholic Fatty Liver Disease (NAFLD) in these regions, from 2013 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

[email protected]

+19376349940
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Business industry report
Phone 9376349940
Business Address Renuka Apartment
Dandekar pool
Country India
Categories Business , Health , Services
Tags global nonalcoholic fatty liver disease nafld industry analysis , global nonalcoholic fatty liver disease nafld market , global nonalcoholic fatty liver disease nafld market share , global nonalcoholic fatty liver disease nafld market size , global nonalcoholic fatty liver disease nafld market trends , nonalcoholic fatty liver disease nafld forecast , nonalcoholic fatty liver disease nafld market key vendors , nonalcoholic fatty liver disease nafld previous data
Last Updated June 1, 2019